Skip to main content
SpringerLink
Log in

No Demonstrable Effect of Benzathine Penicillin on Recurrence of Rheumatic Fever in Pacific Island Population

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Compliance with secondary antibiotic prophylaxis for acute rheumatic fever (ARF) should decrease the rate of recurrence; however, efficacy in a highly endemic area has not been studied. A retrospective chart review of patients <21 years old with a diagnosis of ARF in the Northern Mariana Islands was performed. Patient compliance with benzathine penicillin G (BPG) prophylaxis was assessed. One hundred forty-four patients with ARF were identified and considered eligible, and the recurrence rate was 38%. Mean level of compliance with BPG was 59% in patients with no recurrence of ARF and 57% in patients with recurrence of ARF. Level of compliance was not shown to be associated with odds of recurrence. There was a trend toward significance (p = 0.06), with those patients who had carditis at the time of diagnosis of ARF having higher odds of recurrence. A remarkably high recurrence rate of ARF was found in this population, but there was no difference in compliance with secondary antibiotic prophylaxis between those with and without recurrence of ARF. These findings stress the need to improve methods of primary prevention and secondary antibiotic prophylaxis for ARF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. American Academy of Pediatrics (2006) Group A streptococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan J (eds) Red book: 2006 report of the Committee on Infectious Diseases, 27th edn. American Academy of Pediatrics, Elk Gove Village, pp 610–620

    Google Scholar 

  2. Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I (1998) Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J 17:890–893

    Article  CAS  PubMed  Google Scholar 

  3. Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G (1995) Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 21:1220–1227

    CAS  PubMed  Google Scholar 

  4. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694

    Article  PubMed  Google Scholar 

  5. Crum NF, Hale BR, Bradshaw DA, Malone JD, Chun HM, Gill WM et al (2003) Outbreak of group A streptococcal pneumonia among Marine Corps recruits―California, November 1–December 20, 2002. MMWR Morb Mortal Wkly Rep 52:106–109

    Google Scholar 

  6. Currie BJ (1996) Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? Pediatrics 97:989–991

    CAS  PubMed  Google Scholar 

  7. Eissa S, Lee R, Binns P, Garstone G, McDonald M (2005) Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health 29:521–525

    Article  PubMed  Google Scholar 

  8. Erdem G, Mizumoto C, Esaki D, Abe L, Reddy V, Effler PV (2009) Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr Infect Dis J 28:13–16

    Article  PubMed  Google Scholar 

  9. Gordis L, Markowitz M, Lilienfel AM (1969) Studies in epidemiology and preventability of rheumatic fever. IV. A quantitative determination of compliance in children on oral penicillin prophylaxis. Pediatrics 43:173–182

    CAS  PubMed  Google Scholar 

  10. Grayson S, Horsburgh M, Lennon D (2006) An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J 119:U2255

    PubMed  Google Scholar 

  11. Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J (2006) Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust 184:514–517

    PubMed  Google Scholar 

  12. Hassell TA, Stuart KL (1974) Rheumatic fever prophylaxis: a three-year study. Br Med J 2:39–40

    Article  CAS  PubMed  Google Scholar 

  13. Lue HC, Wu MH, Wang JK, Fen-Fen W, Wu YN (1996) Three- versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 97:984–988

    CAS  PubMed  Google Scholar 

  14. Martin JM, Barbadora KA (2006) Continued high caseload of rheumatic fever in western Pennsylvania: possible rheumatogenic emm types of streptococcus pyogenes. J Pediatr 149:58–63

    Article  PubMed  Google Scholar 

  15. Meira ZMA, Goulart EMA, Colosimo EA, Mota CCC (2005) Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 91:1019–1022

    Article  CAS  PubMed  Google Scholar 

  16. Seckeler MD, Barton LL, Brownstein R (2010) The persistent challenge of rheumatic fever in the Northern Mariana Islands. Int J Infect Dis 14:e226–e229

    Article  PubMed  Google Scholar 

  17. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611–616

    Article  PubMed  Google Scholar 

  18. Stewart T, McDonald R, Currie B (2007) Acute rheumatic fever: adherence to secondary prophylaxis and follow up of indigenous patients in the Katherine region of the Northern Territory. Aust J Rural Health 15:234–240

    Article  PubMed  Google Scholar 

  19. Stollerman GH, Dale JB (2008) The importance of the group A streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis 46:1038–1045

    Article  PubMed  Google Scholar 

  20. Stollerman GH, Rusoff JH (1952) Prophylaxis against group A streptococcal infections in rheumatic fever patients: use of new repository penicillin preparation. J Am Med Assoc 150:1571–1575

    CAS  PubMed  Google Scholar 

  21. Stollerman GH, Rusoff JH, Hirschfeld I (1955) Prophylaxis against group A streptococci in rheumatic fever: the use of single monthly injections of benzathine penicillin G. N Engl J Med 252:787–792

    Article  CAS  PubMed  Google Scholar 

  22. Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J et al (2004) Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113:e168–e172

    Article  PubMed  Google Scholar 

  23. Walker KG, Human DG, DeMoor MMA, Sprenger KJ (1987) The problem of compliance in rheumatic fever. S Afr Med J 72:781–783

    CAS  PubMed  Google Scholar 

  24. Wolfe RR (2000) Incidence of acute rheumatic fever: a persistent dilemma [letter]. Pediatrics 105:1375

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

The authors thank the patients and staff at the Commonwealth Health Center.

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Pediatrics, University of Virginia, P.O. Box 800386, Charlottesville, VA, 22908, USA

    Michael D. Seckeler, Tracey R. Hoke & Matthew J. Gurka

  2. Department of Public Health Sciences, University of Virginia, Charlottesville, VA, 22908, USA

    Matthew J. Gurka

  3. Department of Pediatrics, University of Arizona College of Medicine, Tucson, AZ, 85724, USA

    Leslie L. Barton

Authors
  1. Michael D. Seckeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracey R. Hoke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew J. Gurka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leslie L. Barton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael D. Seckeler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seckeler, M.D., Hoke, T.R., Gurka, M.J. et al. No Demonstrable Effect of Benzathine Penicillin on Recurrence of Rheumatic Fever in Pacific Island Population. Pediatr Cardiol 31, 849–852 (2010). https://doi.org/10.1007/s00246-010-9718-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-010-9718-5

Keywords

Search

Navigation